Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.
Identifieur interne : 000C09 ( PubMed/Curation ); précédent : 000C08; suivant : 000C10Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.
Auteurs : Josef D. J Rhult [Suède]Source :
- Infection ecology & epidemiology [ 2000-8686 ] ; 2012.
Abstract
The antiviral drug oseltamivir (Tamiflu(®)) is a cornerstone in influenza pandemic preparedness plans worldwide. However, resistance to the drug is a growing concern. The active metabolite oseltamivir carboxylate (OC) is not degraded in surface water or sewage treatment plants and has been detected in river water during seasonal influenza outbreaks. The natural influenza reservoir, dabbling ducks, can thus be exposed to OC in aquatic environments. Environmental-like levels of OC induce resistance development in influenza A/H1N1 virus in mallards. There is a risk of resistance accumulation in influenza viruses circulating among wild birds when oseltamivir is used extensively. By reassortment or direct transmission, oseltamivir resistance can be transmitted to humans potentially causing a resistant pandemic or human-adapted highly-pathogenic avian influenza virus. There is a need for more research on resistance development in the natural influenza reservoir and for a prudent use of antivirals.
DOI: 10.3402/iee.v2i0.18385
PubMed: 22957124
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C09
Links to Exploration step
pubmed:22957124Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.</title><author><name sortKey="J Rhult, Josef D" sort="J Rhult, Josef D" uniqKey="J Rhult J" first="Josef D" last="J Rhult">Josef D. J Rhult</name><affiliation wicri:level="1"><nlm:affiliation>Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22957124</idno><idno type="pmid">22957124</idno><idno type="doi">10.3402/iee.v2i0.18385</idno><idno type="wicri:Area/PubMed/Corpus">000C09</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C09</idno><idno type="wicri:Area/PubMed/Curation">000C09</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C09</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.</title><author><name sortKey="J Rhult, Josef D" sort="J Rhult, Josef D" uniqKey="J Rhult J" first="Josef D" last="J Rhult">Josef D. J Rhult</name><affiliation wicri:level="1"><nlm:affiliation>Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala</wicri:regionArea></affiliation></author></analytic><series><title level="j">Infection ecology & epidemiology</title><idno type="eISSN">2000-8686</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The antiviral drug oseltamivir (Tamiflu(®)) is a cornerstone in influenza pandemic preparedness plans worldwide. However, resistance to the drug is a growing concern. The active metabolite oseltamivir carboxylate (OC) is not degraded in surface water or sewage treatment plants and has been detected in river water during seasonal influenza outbreaks. The natural influenza reservoir, dabbling ducks, can thus be exposed to OC in aquatic environments. Environmental-like levels of OC induce resistance development in influenza A/H1N1 virus in mallards. There is a risk of resistance accumulation in influenza viruses circulating among wild birds when oseltamivir is used extensively. By reassortment or direct transmission, oseltamivir resistance can be transmitted to humans potentially causing a resistant pandemic or human-adapted highly-pathogenic avian influenza virus. There is a need for more research on resistance development in the natural influenza reservoir and for a prudent use of antivirals.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">22957124</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2000-8686</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>Infection ecology & epidemiology</Title><ISOAbbreviation>Infect Ecol Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3402/iee.v2i0.18385</ELocationID><Abstract><AbstractText>The antiviral drug oseltamivir (Tamiflu(®)) is a cornerstone in influenza pandemic preparedness plans worldwide. However, resistance to the drug is a growing concern. The active metabolite oseltamivir carboxylate (OC) is not degraded in surface water or sewage treatment plants and has been detected in river water during seasonal influenza outbreaks. The natural influenza reservoir, dabbling ducks, can thus be exposed to OC in aquatic environments. Environmental-like levels of OC induce resistance development in influenza A/H1N1 virus in mallards. There is a risk of resistance accumulation in influenza viruses circulating among wild birds when oseltamivir is used extensively. By reassortment or direct transmission, oseltamivir resistance can be transmitted to humans potentially causing a resistant pandemic or human-adapted highly-pathogenic avian influenza virus. There is a need for more research on resistance development in the natural influenza reservoir and for a prudent use of antivirals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Järhult</LastName><ForeName>Josef D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Ecol Epidemiol</MedlineTA><NlmUniqueID>101579795</NlmUniqueID><ISSNLinking>2000-8686</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H274Y</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">avian</Keyword><Keyword MajorTopicYN="N">oseltamivir carboxylate</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">pharmaceuticals</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>03</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>04</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>04</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22957124</ArticleId><ArticleId IdType="doi">10.3402/iee.v2i0.18385</ArticleId><ArticleId IdType="pii">IEE-2-18385</ArticleId><ArticleId IdType="pmc">PMC3426320</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Virol. 2008 Jan;41(1):13-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18055254</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbiol Rev. 1992 Mar;56(1):152-79</Citation><ArticleIdList><ArticleId IdType="pubmed">1579108</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2010 Jun 4;328(5983):1272-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20522774</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemosphere. 2010 May;79(8):891-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20226496</ArticleId></ArticleIdList></Reference><Reference><Citation>J Wildl Dis. 1993 Oct;29(4):523-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8258848</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(1):e31006</Citation><ArticleIdList><ArticleId IdType="pubmed">22292088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(9):e24742</Citation><ArticleIdList><ArticleId IdType="pubmed">21931841</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1999 Dec;80 ( Pt 12):3167-71</Citation><ArticleIdList><ArticleId IdType="pubmed">10567648</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet Microbiol. 2009 Apr 14;136(1-2):20-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19081209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2006 Jan 28;367(9507):303-13</Citation><ArticleIdList><ArticleId IdType="pubmed">16443037</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1996 Mar 15;217(2):508-16</Citation><ArticleIdList><ArticleId IdType="pubmed">8610442</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e22633</Citation><ArticleIdList><ArticleId IdType="pubmed">21857940</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1993 Sep;67(9):5585-94</Citation><ArticleIdList><ArticleId IdType="pubmed">7688826</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 May 5-11;303(5912):41-4</Citation><ArticleIdList><ArticleId IdType="pubmed">6188957</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010;5(2):e9332</Citation><ArticleIdList><ArticleId IdType="pubmed">20179772</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2011 Aug 26;60(33):1128-32</Citation><ArticleIdList><ArticleId IdType="pubmed">21866086</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Health Perspect. 2010 Jan;118(1):103-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20056566</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Apr 21;312(5772):384-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16627734</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2007;2(10):e986</Citation><ArticleIdList><ArticleId IdType="pubmed">17912363</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2012 Feb 10;335(6069):662-3</Citation><ArticleIdList><ArticleId IdType="pubmed">22267582</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2012;1:CD008965</Citation><ArticleIdList><ArticleId IdType="pubmed">22258996</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 2005 Aug;150(8):1685-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15883657</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Technol. 2010 Mar 1;44(5):1728-35</Citation><ArticleIdList><ArticleId IdType="pubmed">20108960</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemosphere. 2010 Sep;81(3):436-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20673959</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2007 Mar;13(3):404-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17552093</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2009 Sep;86(3):241-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19707215</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2004 Dec;106(2):147-65</Citation><ArticleIdList><ArticleId IdType="pubmed">15567494</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2009;4(6):e6064</Citation><ArticleIdList><ArticleId IdType="pubmed">19557131</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Jul 5;28(30):4709-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20488262</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2009 Jun 5;388(2):270-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19394063</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11709-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19597152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Feb 9;482(7384):155</Citation><ArticleIdList><ArticleId IdType="pubmed">22278057</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Ther. 2009;14(6):751-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19812437</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Oct 23;27(45):6317-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19840667</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Oct;15(10):1686-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19861076</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010;5(1):e8935</Citation><ArticleIdList><ArticleId IdType="pubmed">20126617</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2008 Jul;4(7):e1000103</Citation><ArticleIdList><ArticleId IdType="pubmed">18654625</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Mar 5;360(10):953-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19258250</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Mar;79(5):2814-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15709000</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Apr;15(4):552-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19331731</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1990 Dec;179(2):759-67</Citation><ArticleIdList><ArticleId IdType="pubmed">2238469</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(12):e29778</Citation><ArticleIdList><ArticleId IdType="pubmed">22220216</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Feb 5;14(5). pii: 19112</Citation><ArticleIdList><ArticleId IdType="pubmed">19215715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2004 Aug 28-Sep 3;364(9436):759-65</Citation><ArticleIdList><ArticleId IdType="pubmed">15337401</ArticleId></ArticleIdList></Reference><Reference><Citation>Vector Borne Zoonotic Dis. 2008 Dec;8(6):783-90</Citation><ArticleIdList><ArticleId IdType="pubmed">18637721</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Oct;84(19):9800-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20660186</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2001 Feb 15;183(4):523-31</Citation><ArticleIdList><ArticleId IdType="pubmed">11170976</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2011 Sep;7(9):e1002276</Citation><ArticleIdList><ArticleId IdType="pubmed">21980293</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2005 Oct 10;341(1):102-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16081121</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemosphere. 2010 Sep;81(1):13-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20692015</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2010 Aug;2(8):1510-29</Citation><ArticleIdList><ArticleId IdType="pubmed">21994692</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1978 Feb;84(2):268-78</Citation><ArticleIdList><ArticleId IdType="pubmed">23604</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Nov;78(22):12665-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15507653</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2005 Oct 6;437(7060):889-93</Citation><ArticleIdList><ArticleId IdType="pubmed">16208372</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Cell. 2010 Jan;1(1):9-13</Citation><ArticleIdList><ArticleId IdType="pubmed">21203993</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1993 Jun;194(2):781-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7684877</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2006 Jan;12(1):15-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16494711</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1996 Jan 24-31;275(4):295-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8544269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C09 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000C09 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:22957124
|texte= Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:22957124" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |